Yang Kaiying,Peng Suhua,Chen Siyuan,et al.Current status of diagnosing and treating infantile hepatic hemangioma[J].Journal of Clinical Pediatric Surgery,,19():746-751.[doi:10.3969/j.issn.1671-6353.2020.08.016]
Click Copy

Current status of diagnosing and treating infantile hepatic hemangioma

Journal of Clinical Pediatric Surgery[ISSN:1671-6353/CN:43-1380/R] volume: 第19卷 Number: 2020 08 Page: 746-751 Column: 综述 Date of publication: 2020-08-20
Author(s):
Yang Kaiying1;  Peng Suhua1;  Chen Siyuan2;  Ji Yi1
1. Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu 610041, China;
2. Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China
Keywords:
Infant; Hepatic Hemangioma; Diagnosis and Treatment
CLC:
R657.3;R726
DOI:
10.3969/j.issn.1671-6353.2020.08.016
Abstract:
As the most common benign tumor of liver in children, infantile hepatic hemangioma (IHH) may be classified into three morphologic patterns of focal, multifocal and diffuse. The clinical characteristics and symptoms of 3 different subtypes of IHH vary widely. Major complications of diffuse IHH include consumptive hypothyroidism, heart failure and abdomen compartment syndrome. As demonstrated by recent studies, two risk factor for IHH and death are multiple cutaneous infantile hemangiomas and diffuse IHH. Oral propranolol is efficacious for multifocal and diffuse IHHs. For providing guidance for diagnosing and treating IHH, this review focuses upon the clinical characteristics, major complications, risk factors, imaging manifestations, pathological features and treatments of IHH.

References:

1 Hsi Dickie B,Fishman SJ,Azizkhan RG.Hepatic vascular tumors[J].Semin Pediatr Surg,2014,23(4):168-172.DOI:10.1053/j.sempedsurg.2014.06.018.
2 Kassarjian A,Zurakowski D,Dubois J,et al.Infantile hepatic hemangiomas:clinical and imaging findings and their correlation with therapy[J].AJR Am J Roentgenol,2004,182(3):785-795.DOI:10.2214/ajr.182.3.1820785.
3 Christison-Lagay ER,Burrows PE,Alomari A,et al.Hepatic hemangiomas:subtype classification and development of a clinical practice algorithm and registry[J].J Pediatr Surg,2007,42(1):62-67;discussion67-68.DOI:10.1016/j.jpedsurg.2006.09.041.
4 Dasgupta R,Fishman SJ.ISSVA classification[J].Semin Pediatr Surg,2014,23(4):158-161.DOI:10.1053/j.sempedsurg.2014.06.016.
5 Kulungowski AM,Alomari AI,Chawla AA,et al.Lessons from a liver hemangioma registry:subtype classification[J].J Pediatr Surg,2012,47(1):165-170.DOI:10.1016/j.jpedsurg.2011.10.037.
6 Rialon KL,Murillo R,Fevurly RD,et al.Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas[J].J Pediatr Surg,2015,50(5):837-841.DOI:10.1016/j.jpedsurg.2014.09.056.
7 Rialon KL,Murillo R,Fevurly RD,et al.Impact of screening for hepatic hemangiomas in patients with multiple cutaneous infantile hemangiomas[J].Pediatric Dermatology,2015,32(6):808-812.DOI:10.1111/pde.12656.
8 Ji Y,Chen S,Xiang B,et al.Clinical features and management of multifocal hepatic hemangiomas in children:a retrospective study[J].Sci Rep,2016,6:31744.DOI:10.1038/srep31744.
9 Li K,Wang Z,Liu Y,et al.Fine clinical differences between patients with multifocal and diffuse hepatic hemangiomas[J].J Pediatr Surg,2016,51(12):2086-2090.DOI:10.1016/j.jpedsurg.2016.09.045.
10 Hernandez F,Navarro M,Encinas JL,et al.The role of GLUT1 immunostaining in the diagnosis and classification of liver vascular tumors in children[J].J Pediatr Surg,2005,40(5):801-804.DOI:10.1016/j.jpedsurg.2005.01.046.
11 Roebuck D,Sebire N,Lehmann E,et al.Rapidly involuting congenital haemangioma (RICH) of the liver[J].PediatrRadiol,2012,42(3):308-314.DOI:10.1007/s00247-011-2268-z.
12 Gnarra M,Behr G,Kitajewski A,et al.History of the infantile hepatic hemangioma:From imaging to generating a differential diagnosis[J].World J Clin Pediatr,2016,5(3):273-280.DOI:10.5409/wjcp.v5.i3.273.
13 Isaacs H Jr.Fetal and neonatal hepatic tumors[J].J Pediatr Surg,2007,42(11):1797-1803.DOI:10.1016/j.jpedsurg.2007.07.047.
14 Huang SA,Tu HM,Harney JW,et al.Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas[J].N Engl J Med,2000,343(3):185-189.DOI:10.1056/NEJM200007203430305.
15 Varrasso G,Schiavetti A,Lanciotti S,et al.Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma:a case report[J].Hepatology,2017,66(1):283-285.DOI:10.1002/hep.29028.
16 Higuchi S,Takagi M,Hasegawa Y.Use of liothyronine without levothyroxine in the treatment of mild consumptive hypothyroidism caused by hepatic hemangiomas[J].Endocr J,2017,64(6):639-643.DOI:10.1507/endocrj.EJ16-0559.
17 Jabbar A,Pingitore A,Pearce SH,et al.Thyroid hormones and cardiovascular disease[J].Nat Rev Cardiol,2017,14(1):39-55.DOI:10.1038/nrcardio.2016.174.
18 De Waele JJ,De Laet I,Malbrain ML.Understanding abdominal compartment syndrome[J].Intensive Care Med,2016,42(6):1068-1070.DOI:10.1007/s00134-015-4089-2.
19 Warren,Diaz L,Levy M.Diffuse Hepatic Hemangiomas Successfully Treated Using Sirolimus and High-Dose Propranolol[J].Pediatr Dermatol,2017,34(5):e286-e287.DOI:10.1111/pde.13219.
20 Zhang Z,Chen HJ,Yang WJ,et al.Infantile hepatic hemangioendothelioma:a clinicopathologic study in a Chinese population[J].World J Gastroenterol,2010,16(36):4549-4557.DOI:10.3748/wjg.v16.i36.4549.
21 Fernandez-Pineda I,Cabello-Laureano R.Differential diagnosis and management of liver tumors in infants[J].World J Hepatol,2014,6(7):486-495.DOI:10.4254/wjh.v6.i7.486.
22 Sharma D,Subbarao G,Saxena R.Hepatoblastoma[J].Semin Diagn Pathol,2017,34(2):192-200.DOI:10.1053/j.semdp.2016.12.015.
23 Stringer MD,Alizai NK.Mesenchymal hamartoma of the liver:a systematic review[J].J Pediatr Surg,2005,40(11):1681-1690.DOI:10.1016/j.jpedsurg.2005.07.052.
24 Putra J,Ornvold K.Undifferentiated embryonal sarcoma of the liver:a concise review[J].Arch Pathol Lab Med,2015,139(2):269-273.DOI:10.5858/arpa.2013-0463-RS.
25 Dickie B,Dasgupta R,Nair R,et al.Spectrum of hepatic hemangiomas:management and outcome[J].J Pediatr Surg,2009,44(1):125-133.DOI:10.1016/j.jpedsurg.2008.10.021.
26 Kuroda T,Hoshino K,Nosaka S,et al.Critical hepatic hemangioma in infants:recent nationwide survey in Japan[J].Pediatr Int,2014,56(3):304-308.DOI:10.1111/ped.12347.
27 George ME,Sharma V,Jacobson J,et al.Adverse effects of systemic glucocorticosteroidtherapy in infants with hemangiomas[J].Arch Dermatol,2004,140(8):963-969.DOI:10.1001/archderm.140.8.963.
28 Leaute-Labreze C,Dumas De La Roque E,Hubiche T,et al.Propranolol for severe hemangiomas of infancy[J].N Engl J Med,2008,358(24):2649-2651.DOI:10.1056/NEJMc0708819.
29 Drolet BA,Frommelt PC,Chamlin SL,et al.Initiation and use of propranolol for infantile hemangioma:report of a consensus conference[J].Pediatrics,2013,131(1):128-140.DOI:10.1542/peds.2012-1691.
30 刘超,张蕾,李香,等.阶梯加量法"口服普萘洛尔"治疗婴幼儿血管瘤疗效分析[J].临床小儿外科杂志,2016,15(6):590-593.DOI:10.3969/j.issn.1671-6353.2016.06.018.Liu C,Zhang L,Li X,et al.Treatment of infantile hemangioma by oral "ladder dosage" propranolol:a study of 56 cases[J].J Clin Ped Sur,2016,15(6):590-593.DOI:10.3969/j.issn.1671-6353.2016.06.018.
31 Prey S,Voisard JJ,Delarue A,et al.Safety of propranolol therapy for severe infantile hemangioma[J].JAMA,2016,315(4):413-415.DOI:10.1001/jama.2015.13969.
32 Kim KH,Choi TH,Choi Y,et al.Comparison of efficacy and safety between propranolol and steroid for infantile hemangioma:a randomized clinical trial[J].JAMA dermatol,2017,153(6):529-536.DOI:10.1001/jamadermatol.2017.0250.
33 Bauman NM,Mccarter RJ,Guzzetta PC,et al.Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas:a randomized clinical trial[J].JAMA Otolaryngol Head Neck Surg, 2014,140(4):323-330.DOI:10.1001/jamaoto.2013.6723.
34 Ji Y,Chen S,Xu C,et al.The use of propranolol in the treatment of infantile haemangiomas:an update on potential mechanisms of action[J].Br J Dermatol,2015,172(1):24-32.DOI:10.1111/bjd.13388.
35 Vergine G,Marsciani A,Pedini A,et al.Efficacy of propranolol treatment in thyroid dysfunction associated with severe infantile hepatic hemangioma[J].Horm Res Paediatr,2012,78(4):256-260.DOI:10.1159/000337253.
36 Sciveres M,Marrone G,Pipitone S,et al.Successful first-line treatment with propranolol of multifocal infantile hepatic hemangioma with high-flow cardiac overload[J].J Pediatr Gastroenterol Nutr,2011,53(6):693-695.DOI:10.1097/MPG.0b013e3182201a4e.
37 Konrad D,Ellis G,Perlman K.Spontaneous regression of severe acquired infantile hypothyroidism associated with multiple liver hemangiomas[J].Pediatrics,2003,112(6 Pt 1):1424-1426.
38 Hughes JA,Hill V,Patel K,et al.Cutaneous haemangioma:prevalence and sonographic characteristics of associated hepatic haemangioma[J].Clin Radiol,2004,59(3):273-280.DOI:10.1016/S0009-9260(03)00267-8.
39 Horii KA,Drolet BA,Frieden IJ,et al.Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas[J].Pediatr Dermatol,2011,28(3):245-253.DOI:10.1111/j.1525-1470.2011.01420.x.
40 Vredenborg AD,Janmohamed SR,De Laat PC,et al.Multiple cutaneous infantile haemangiomas and the risk of internal haemangioma[J].Br J Dermatol,2013,169(1):188-191.DOI:10.1111/bjd.12229.

Memo

收稿日期:2018-09-16。
基金项目:国家自然科学基金资助项目（编号：81401606/81400862）；四川大学优秀青年学者基金资助项目（编号：2015SU04A15）；四川大学华西医院学科卓越发展1·3·5工程临床研究孵化项目（编号：2019HXFH056）；四川省科技厅重点研发项目（编号：2019YFS03202）
通讯作者:吉毅,Email:jijiyuanyuan@163.com;陈思源,Email:siy_chen@163.com

Last Update: 1900-01-01